» Articles » PMID: 14701708

Oxidative Stress in Severe Pulmonary Hypertension

Overview
Specialty Critical Care
Date 2004 Jan 1
PMID 14701708
Citations 159
Authors
Affiliations
Soon will be listed here.
Abstract

Severe pulmonary hypertension (PH) occurs in a primary or "unexplained" form and in a group of secondary forms associated with a number of diseases. Because the lung tissue from patients with severe PH demonstrates complex vascular lesions, which contain inflammatory cells, we wondered whether the lung tissue from patients with severe PH was "under oxidative stress." We used immunohistochemistry to localize nitrotyrosine and 8-hydroxy guanosine in the lung tissue sections from patients with primary and secondary PH. In some lung tissue extracts, the eicosanoid metabolites 5-oxo-eicosatetraenoic acid, leukotriene B4 5-hydroxyeicosatetraenoic acid (HETE), 12-HETE, and 15-HETE were measured using mass spectroscopy, and superoxide dismutase amount and activity were measured. Nitrotyrosine expression was ubiquitous in all PH lungs, and 5-oxo-eicosatetraenoic acid and HETE levels were elevated in the lungs of patients with severe PH but not in those lungs that were from the patients with severe PH treated chronically with prostacyclin. We conclude that indeed the lungs from patients with severe PH are under oxidative stress and that chronic prostacyclin infusion has an antiinflammatory effect on the lung tissue.

Citing Articles

High-altitude pulmonary hypertension: a comprehensive review of mechanisms and management.

Yang X, Liu H, Wu X Clin Exp Med. 2025; 25(1):79.

PMID: 40063280 PMC: 11893705. DOI: 10.1007/s10238-025-01577-3.


The G-protein coupled receptor OXER1 is a tissue redox sensor essential for intestinal epithelial barrier integrity.

Lengyel M, Ma Y, Gelashvili Z, Peng S, Quraishi M, Niethammer P bioRxiv. 2025; .

PMID: 39974905 PMC: 11839128. DOI: 10.1101/2025.02.05.636712.


Portopulmonary hypertension: Current developments and future perspectives.

Xu H, Cheng B, Wang R, Ding M, Gao Y Liver Res. 2025; 6(1):10-20.

PMID: 39959808 PMC: 11791819. DOI: 10.1016/j.livres.2022.02.002.


Mechanisms and treatment of pulmonary arterial hypertension.

Ghofrani H, Gomberg-Maitland M, Zhao L, Grimminger F Nat Rev Cardiol. 2024; 22(2):105-120.

PMID: 39112561 DOI: 10.1038/s41569-024-01064-4.


Hypoxia-Induced Pulmonary Injury-Adrenergic Blockade Attenuates Nitrosative Stress, and Proinflammatory Cytokines but Not Pulmonary Edema.

Riha I, Salameh A, Hoschke A, Raffort C, Koedel J, Rassler B J Cardiovasc Dev Dis. 2024; 11(7).

PMID: 39057617 PMC: 11277000. DOI: 10.3390/jcdd11070195.